Biomarkers associated with clinical phenotypes of hand osteoarthritis in a large multigenerational family: the CARRIAGE family study

Osteoarthritis and Cartilage

Volumn 16, Issue 9, 2008, Pages 1054-1059

  Chen, H C ^a,b   Shah, S ^a   Stabler, T V ^a   Li, Y J ^a   Kraus, V B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Biomarkers; Genetics; Hand; Osteoarthritis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGEN N PROPEPTIDE TYPE 2; HYALURONIC ACID; NEOEPITOPE FROM CLEAVAGE OF COLLAGEN TYPE 2; PLASMA PROTEIN; PROCOLLAGEN; PROCOLLAGEN CARBOXY PROPEPTIDE TYPE 2;

ADULT; AGED; ARTHROPATHY; ARTICLE; BLOOD SAMPLING; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FEMALE; GENETIC SUSCEPTIBILITY; HAND OSTEOARTHRITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; OSTEOARTHRITIS; PHENOTYPE; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE TRAIT; SYMPTOM; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COLLAGEN TYPE II; EXTRACELLULAR MATRIX PROTEINS; FAMILY; FEMALE; GLYCOPROTEINS; HAND; HUMANS; HYALURONIC ACID; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OSTEOARTHRITIS; PEDIGREE; PHENOTYPE; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 49149131671     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2007.12.010     Document Type: Article

References (31)

1. Lawrence R.C., Helmick C.G., Arnett F.C., Deyo R.A., Felson D.T., Giannini E.H., et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41 (1998) 778-799
2. Hogue J.H., and Mersfelder T.L. Pathophysiology and first-line treatment of osteoarthritis. Ann Pharmacother 36 (2002) 679-686
3. Elders M.J. The increasing impact of arthritis on public health. J Rheumatol Suppl 60 (2000) 6-8
4. Peach C.A., Carr A.J., and Loughlin J. Recent advances in the genetic investigation of osteoarthritis. Trends Mol Med 11 (2005) 186-191
5. Jordan J.M., Kraus V.B., and Hochberg M.C. Genetics of osteoarthritis. Curr Rheumatol Rep 6 (2004) 7-13
6. Chapman K., Mustafa Z., Irven C., Carr A.J., Clipsham K., Smith A., et al. Osteoarthritis-susceptibility locus on chromosome 11q, detected by linkage. Am J Hum Genet 65 (1999) 167-174
7. Loughlin J., Mustafa Z., Irven C., Smith A., Carr A.J., Sykes B., et al. Stratification analysis of an osteoarthritis genome screen-suggestive linkage to chromosomes 4, 6, and 16. Am J Hum Genet 65 (1999) 1795-1798
8. Leppavuori J., Kujala U., Kinnunen J., Kaprio J., Nissila M., Heliovaara M., et al. Genome scan for predisposing loci for distal interphalangeal joint osteoarthritis: evidence for a locus on 2q. Am J Hum Genet 65 (1999) 1060-1067
9. Stefansson S.E., Jonsson H., Ingvarsson T., Manolescu I., Jonsson H.H., Olafsdottir G., et al. Genomewide scan for hand osteoarthritis: a novel mutation in matrilin-3. Am J Hum Genet 72 (2003) 1448-1459
10. Demissie S., Cupples L.A., Myers R., Aliabadi P., Levy D., and Felson D.T. Genome scan for quantity of hand osteoarthritis: the Framingham study. Arthritis Rheum 46 (2002) 946-952
11. Greig C., Spreckley K., Aspinwall R., Gillaspy E., Grant M., Ollier W., et al. Linkage to nodal osteoarthritis: quantitative and qualitative analyses of data from a whole-genome screen identify trait-dependent susceptibility loci. Ann Rheum Dis 65 (2006) 1131-1138
12. Hunter D.J., Demissie S., Cupples L.A., Aliabadi P., and Felson D.T. A genome scan for joint-specific hand osteoarthritis susceptibility: the Framingham Study. Arthritis Rheum 50 (2004) 2489-2496
13. Livshits G., Kato B.S., Zhai G., Hart D.J., Hunter D., MacGregor A.J., et al. Genomewide linkage scan of hand osteoarthritis in female twin pairs showing replication of quantitative trait loci on chromosomes 2 and 19. Ann Rheum Dis 66 (2007) 623-627
14. Kraus V.B., Jordan J.M., Doherty M., Wilson A.G., Moskowitz R., Hochberg M., et al. The Genetics of Generalized Osteoarthritis (GOGO) study: study design and evaluation of osteoarthritis phenotypes. Osteoarthritis Cartilage 15 (2007) 120-127
15. Bauer D.C., Hunter D.J., Abramson S.B., Attur M., Corr M., Felson D., et al. Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage 14 (2006) 723-727
16. Rousseau J.C., and Delmas P.D. Biological markers in osteoarthritis. Nat Clin Pract Rheumatol 3 (2007) 346-356
17. Charni-Ben Tabassi N., and Garnero P. Monitoring cartilage turnover. Curr Rheumatol Rep 9 (2007) 16-24
18. Altman R.D., Fries J.F., Bloch D.A., Carstens J., Cooke T.D., Genant H., et al. Radiographic assessment of progression in osteoarthritis. Arthritis Rheum 30 (1987) 1214-1225
19. Vilim V., Olejarova M., Machacek S., Gatterova J., Kraus V.B., and Pavelka K. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage 10 (2002) 707-713
20. Elliott A.L., Kraus V.B., Luta G., Stabler T., Renner J.B., Woodard J., et al. Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis Project. Arthritis Rheum 52 (2005) 105-111
21. Wang Y., Dou C., Yuan C., and Datta A. Development of an automated enzymatic assay for the determination of glycated serum protein in human serum. Clin Chem 51 (2005) 1991-1992
22. Jordan J.M., Luta G., Stabler T., Renner J.B., Dragomir A.D., Vilim V., et al. Ethnic and sex differences in serum levels of cartilage oligomeric matrix protein: the Johnston County Osteoarthritis Project. Arthritis Rheum 48 (2003) 675-681
23. Sharif M., Kirwan J., Charni N., Sandell L.J., Whittles C., and Garnero P. A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis - association with disease progression. Rheumatology (Oxford) 46 (2007) 938-943
24. Rousseau J.C., Sandell L.J., Delmas P.D., and Garnero P. Development and clinical application in arthritis of a new immunoassay for serum type IIA procollagen NH2 propeptide. Methods Mol Med 101 (2004) 25-37
25. Rousseau J.C., Zhu Y., Miossec P., Vignon E., Sandell L.J., Garnero P., et al. Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage 12 (2004) 440-447
26. Garnero P., Ayral X., Rousseau J.C., Christgau S., Sandell L.J., Dougados M., et al. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum 46 (2002) 2613-2624
27. Sturmer T., Brenner H., Koenig W., and Gunther K.P. Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein. Ann Rheum Dis 63 (2004) 200-205
28. Spector T.D., Hart D.J., Nandra D., Doyle D.V., Mackillop N., Gallimore J.R., et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 40 (1997) 723-727
29. DeGroot J., Verzijl N., Wenting-van Wijk M.J., Jacobs K.M., Van El B., Van Roermund P.M., et al. Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis. Arthritis Rheum 50 (2004) 1207-1215
30. Verzijl N., DeGroot J., Ben Z.C., Brau-Benjamin O., Maroudas A., Bank R.A., et al. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum 46 (2002) 114-123
31. Senolt L., Braun M., Olejarova M., Forejtova S., Gatterova J., and Pavelka K. Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein. Ann Rheum Dis 64 (2005) 886-890